Autori: Lanna C., Rivieccio A., Cattani C., Artosi F., Bianchi L., Campione E.
Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits. Journal of Dermatological Treatment, 2025 (June). DOI: 10.1080/09546634.2025.2512159